US Patent Issued to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE DE LILLE, INSTITUT PASTEUR DE LILLE, UNIVERSITE DE MONTPELLIER, INSTITUT REGIONAL DU CANCER DE MONTPELLIER on Nov. 4 for "Monoclonal antibodies specific for IL20-Rb, encoding nucleic acids thereof and methods of use thereof to treat bacterial-induced exacerbation of chronic obstructive pulmonary disease" (French Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,460,009, issued on Nov. 4, was assigned to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Paris), UNIVERSITE DE LILLE (Paris), INSTITUT PASTEUR DE LILLE (Lille, France), UNIVERSITE DE MONTPELLIER (Montpellier, France) and INSTITUT REGIONAL DU CANCER DE MONTPELLIER (Montpellier, France).

"Monoclonal antibodies specific for IL20-Rb, encoding nucleic acids thereof and methods of use thereof to treat bacterial-induced exacerbation of chronic obstructive pulmonary disease" was invented by Philippe Gosset (Lille, France), Muriel Pichavant (Lille, France), Pierre Martineau (Montpellier, France), Myriam Chentouf ...